Pancreatic Cancer Research

ResearcherUniversity of Occupational and Environmental Health JapanNo recent work listed

Masanori Hisaoka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6593-5040; OpenAlex author ID A5039403070. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper

Papers 4

  1. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.12.007↗
  2. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma. First author DOI 10.7888/juoeh.38.1↗
  3. Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00428-014-1642-2↗
  4. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. First author DOI 10.1038/modpathol.2011.142↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mitsuhiro Nakamoto · 2 shared papers, 2014–2016 · strength 0.17
  2. Atsuhiro Koga · 1 shared paper, 2017 · strength 0.08
  3. Shiro Kohi · 1 shared paper, 2017 · strength 0.08
  4. Xiaobo Cheng · 1 shared paper, 2017 · strength 0.08
  5. Keiji Hirata · 1 shared paper, 2017 · strength 0.08
  6. Norihiro Sato · 1 shared paper, 2017 · strength 0.08
  7. Koji Yamaguchi · 2 shared papers, 2012–2014 · strength 0.08
  8. Yuichi Nagao · 1 shared paper, 2012 · strength 0.03
  9. Hiroshi Hashimoto · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.